{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:35:56Z","timestamp":1793414156904,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2021\\u20131541"],"award-info":[{"award-number":["2021\\u20131541"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005699","name":"Universit\u00e0 degli Studi del Piemonte Orientale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009885","name":"Piedmont Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.vaccine.2025.126723","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T22:38:17Z","timestamp":1737153497000},"page":"126723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination"],"prefix":"10.1016","volume":"48","author":[{"given":"Davide","family":"Raineri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Barbero","family":"Mazzucca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Moia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Kustrimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cappellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Bellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Perazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126723_bb0005","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11912-022-01198-z","article-title":"Chronic lymphocytic leukemia in the SARS-CoV-2 pandemic","volume":"24","author":"Arellano-Llamas","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.vaccine.2025.126723_bb0015","series-title":"Molecular Sciences Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions","author":"Arruga","year":"2024"},{"key":"10.1016\/j.vaccine.2025.126723_bb0025","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1080\/10428194.2018.1457147","article-title":"Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia","volume":"59","author":"Pleyer","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.vaccine.2025.126723_bb0030","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.vaccine.2021.01.001","article-title":"The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)","volume":"39","author":"Whitaker","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126723_bb0035","series-title":"C A N C E R E P I D E M I O L O G Y Cancer Associates with Risk and Severe Events of COVID-19: A Systematic Review and Meta-Analysis","author":"Tian","year":"2020"},{"key":"10.1016\/j.vaccine.2025.126723_bb0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with Cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.vaccine.2025.126723_bb0045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/2159-8290.CD-20-0773","article-title":"Clinical portrait of the SARS-CoV-2 epidemic in European Cancer patients","volume":"10","author":"Pinato","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.vaccine.2025.126723_bb0050","article-title":"Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-Cancer therapy-naive patients. Blood","volume":"12","author":"Borgogna","year":"2022","journal-title":"Cancer J"},{"key":"10.1016\/j.vaccine.2025.126723_bb0055","article-title":"Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies. Blood","volume":"11","author":"Malard","year":"2021","journal-title":"Cancer J"},{"key":"10.1016\/j.vaccine.2025.126723_bb0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0953-6205(01)00149-2","article-title":"Influenza virus vaccination and booster in B-cell chronic lymphocytic Leukaemia patients","volume":"12","author":"Van der Velden","year":"2001","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.vaccine.2025.126723_bb0065","article-title":"Response to the Conjugate Pneumococcal Vaccine (PCV13) in Patients with Chronic Lymphocytic Leukemia (CLL)","author":"Mauro","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.vaccine.2025.126723_bb0070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0264-410X(00)00409-6","article-title":"Antibody responses to pneumococcal and Haemophilus vaccinations in patients with B-cell chronic lymphocytic Leukaemia","volume":"19","author":"Hartkamp","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126723_bb0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood.2020008758","article-title":"Effect of Bruton tyrosine kinase inhibitor on efficacy of Adjuvanted recombinant hepatitis B and zoster vaccines","volume":"137","author":"Pleyer","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0080","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","article-title":"Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 MRNA vaccination","volume":"54","author":"Painter","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2025.126723_bb0085","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2023.113443","article-title":"An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: application to SARS-CoV-2 immune individuals","volume":"515","author":"Altosole","year":"2023","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2025.126723_bb0095","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 MRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bjh.18014","article-title":"COVID-19 vaccine failure in chronic lymphocytic Leukaemia and monoclonal B-lymphocytosis; Humoural and cellular immunity","volume":"197","author":"Shen","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0105","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1080\/10428194.2021.1957877","article-title":"Low rate of seroconversion after MRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies","volume":"62","author":"Re","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.vaccine.2025.126723_bb0110","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 MRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0115","first-page":"374","article-title":"MRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern","volume":"2021","author":"Goel","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.126723_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamaneurol.2022.0245","article-title":"Omicron-specific cytotoxic T-cell responses after a third dose of MRNA COVID-19 vaccine among patients with multiple sclerosis treated with Ocrelizumab","volume":"79","author":"Madelon","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0125","first-page":"36","article-title":"Adaptive Immunity and Neutralizing Antibodies against SARS-CoV-2 Variants of Concern Following Vaccination in Patients with Cancer: The CAPTURE Study","volume":"2","author":"Fendler","year":"2024","journal-title":"Christina Messiou"},{"key":"10.1016\/j.vaccine.2025.126723_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186998","article-title":"Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells","volume":"12","author":"Reiss","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126723_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186998","article-title":"Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells","volume":"12","author":"Reiss","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126723_bb0140","first-page":"371","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"2021","author":"Dan","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.126723_bb0145","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0150","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/bjh.15918","article-title":"Chronic lymphocytic Leukaemia: the role of T cells in a B cell disease","volume":"186","author":"Man","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0160","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3324\/haematol.2022.280982","article-title":"SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia","volume":"107","author":"Mellinghoff","year":"2022","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126723_bb0165","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and Strong Memory CD4+ and CD8+ T Cells Induced by SARS-CoV-2 in UK Convalescent Individuals Following COVID-19","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0170","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3324\/haematol.2019.238154","article-title":"Combining Ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice","volume":"106","author":"Hanna","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.vaccine.2025.126723_bb0175","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1172\/JCI89756","article-title":"Ibrutinib treatment improves T cell number and function in CLL patients","volume":"127","author":"Long","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2025.126723_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02832","article-title":"Long-term Ibrutinib therapy reverses CD8+ T cell exhaustion in B cell chronic lymphocytic Leukaemia","volume":"10","author":"Parry","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0190","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2025.126723_bb0195","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.4049\/jimmunol.0800997","article-title":"Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion","volume":"182","author":"Bucks","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106520","article-title":"Impact of Long-term Ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia","volume":"102","author":"Solman","year":"2021","journal-title":"Leuk Res"},{"key":"10.1016\/j.vaccine.2025.126723_bb0205","article-title":"Altered T follicular helper cell subsets and function in chronic lymphocytic leukemia","volume":"11","author":"Wu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.vaccine.2025.126723_bb0210","doi-asserted-by":"crossref","first-page":"22443","DOI":"10.1038\/s41598-024-73325-8","article-title":"Exploring the prognostic value of T follicular helper cell levels in chronic lymphocytic leukemia","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:20:50Z","timestamp":1777537250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S0264410X25000209"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126723","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impairment of the T cell memory response in chronic lymphocytic leukemia patients after SARS-CoV-2 vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126723"}}